Mechanism and action
Tirzepatide targets both GLP-1 and GIP receptors, signalling the pancreas to regulate insulin, slowing gastric emptying to promote fullness, and influencing brain hunger centres to reduce appetite and cravings. It was developed to manage blood sugar in type 2 diabetes and is administered as a once-weekly self-injection under physician supervision.
Clinical effect and tolerability depend on dose and individual response. Because the medication works through multiple pathways—insulin regulation, slower digestion and appetite modulation—results and side effects vary, which is why the physician supervises treatment and uses follow-up to assess benefit and tolerability.
Candidate selection and criteria
Good candidates are healthy adults with a body mass index over 30, or a BMI over 27 with at least one weight-related health condition. Candidates should be committed to balanced nutrition and regular exercise; lifestyle adherence is an essential component of how this therapy is intended to be used.
Certain medical histories exclude use: medullary thyroid cancer, gallbladder disease, pancreatitis or multiple endocrine neoplasia type 2 are not recommended for this treatment. The physician reviews your health history and medications to determine if tirzepatide is appropriate and safe for you.
Treatment process in Beverly Hills
Treatment begins with a physician consultation that includes a comprehensive health-history review and laboratory evaluation to confirm eligibility and guide dosing. Our Beverly Hills office near the Golden Triangle and Rodeo Drive schedules appointments to fit workdays, shopping trips or hotel stays, with easy access from Santa Monica and Wilshire Boulevards and Metro connections.
Dosing options range from 1.5 mg to 7.5 mg per week and are individualized based on response and tolerability. Staff teach the once-weekly self-injection technique, review storage and disposal, and set a follow-up plan. Pricing at the practice is listed from $99 - $250, with final cost depending on visit components and testing.

